Filter
519
Text search:
D.
Walker
Featured
40
79
Language
Document type
243
134
69
41
13
10
4
3
2
Countries / Regions
26
13
10
10
10
9
9
8
7
7
6
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
119
40
39
36
15
5
3
Toolboxes
87
46
38
36
22
22
20
18
13
12
10
10
10
7
6
6
5
5
4
3
2
2
1
1
An Evidence-Based Treatment Guide for Clinicians
Open access book describing tools for engaging communities in resilience strategies
Based on practical experience from participatory positive futures visioning in nine Latin American and US cities
For students and professionals of different sectors including sustainability, engineering, ec
...
Achieving financial risk protection for the whole population requires significant financing for health. Health systems in low- and middle-income countries (LMIC) are plagued with persistent underfunding, and recent reductions in official development assistance have been registered. To create fiscal
...
PLoS ONE 7(12): e52986. doi:10.1371/journal.pone.0052986. Opern Access please download from the website
Introduction
Chapter A.5
Introduction
Chapitre A.5
Edition en français
Traduction : Eleanor O’Boyle
Sous la direction de : Priscille Gérardin
Avec le soutien de la SFPEADA
Introducción
Capítulo A.5
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Carlos Llanes
A guide for practical implementation in adult and pediatric emergency department and urgent care settings
A summary of what we know
DHS Working Papers No. 110 | Zimbabwe Working Papers No. 11
Special issue: Mental Health Challenges in Lithuania
Nos. 1-2 '11
J Mov Disord > Volume 11(2); 2018 > Article
Review Article
J Mov Disord 2018; 11(2): 53-64.
Published online: May 30, 2018
DOI: https://doi.org/10.14802/jmd.17028
Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr
...
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
